Skip to main content

Table 3 Patient profile

From: HIV-1 mutational pathways under multidrug therapy

Patient demographics

Age 1st genotyping

39.7 years

± 9.3

Gender (M/F)

1054 M

433 F

Num prev therps

4 (median)

0-32 (range)

Days between genotypings

485 (mean)

639 (variance)

Risk group:

  

Heterosexual

450

30%

Homo/bisexual

367

25%

IVDA

372

25%

Vertical transmission

33

2%

Blood products

25

2%

Other/unknown

245

16%

  1. Background data on the subjects included in the study. When a subject has contributed multiple therapy records to the study, the demographic information is taken from the first therapy included.
Back to article page

AIDS Research and Therapy

ISSN: 1742-6405

Contact us